GLP-1 receptor agonists for obesity: eligibility across 99 countries
Washington University in St. Louis · Emory University · +39 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
5
total citations
- FWCI
- 74.51
- Percentile
- 100%
- References
- 9
Too recent for citation history.
Authors
47- SGSang Gune K YooCorresponding
Washington University in St. Louis
- FTFelix Teufel
Emory University
- MTMichaela Theilmann
Brigham and Women's Hospital
- YSYajuan Si
University of Michigan
- EAElhadji Amadou Touré
Brigham and Women's Hospital
Topics & keywords
Topics
Keywords
- Diabetes mellitus
- MEDLINE
- Agonist
- Diabetes treatment
- Receptor
- Center (category theory)
No related works found for this paper.
Funding
- BABill and Melinda Gates Foundation
- AAstraZeneca
- BABrigham and Women's Hospital
- MGMassachusetts General Hospital
- EUEmory University
- HUHarvard University
- UOUniversity of MichiganAward: P30DK092926
- NFNovartis Foundation
- QMQueen Mary University of London
- SOSchool of Public Health, University of Michigan
- PHPublic Health Agency
- UOUniversity of New South Wales
- IHIndus Hospital
- NNNovo Nordisk
- USUniversiteit Stellenbosch
- TUTehran University of Medical Sciences and Health Services
- UAUniversidad Autónoma de Madrid
- UIUniversitetet i Bergen
- UDUniversidade do Porto
- UOUniversity of Cape Town
- BMBaqai Medical University
- UFUniversidade Federal de Minas Gerais
- WHWorld Heart Federation
- GIGeorge Institute for Global Health
- NINational Institutes of HealthAwards: T32 HL007081, P30DK092926, 5P30AG024824, K23HL161271
- DODepartment of Global Health and Population, Harvard T.H. Chan School of Public Health
- MDMichigan Diabetes Research Center, University of Michigan
- MRMedical Research Council
- MFMedizinische Fakultät, Heinrich-Heine-Universität Düsseldorf
- FOFaculty of Medicine and Health, University of Sydney
- NHNational Heart, Lung, and Blood InstituteAwards: T32 HL007081, K23HL161271